Recombinant human Insulin-like growth factor binding protein 4, N-terminal fragment (NT-IGFBP-4)

Cat.# 8NGP4

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers

Price:
-- / 0.05 mg
* All prices excluding VAT
Request an offer
Cardiac markers
  • Cat.#

    8NGP4

  • Source:

    Expressed in a mammalian cell line

  • Description:

    Amino-terminal fragment of insulin-like growth factor binding protein-4 (amino acid residues Asp22-Met156). Accession number UniProt P22692.

    Does not contains any tags

    Theoretical molecular weight 14 640 Da

    Theoretical pI 6.32

  • Applications:

    Biochemical studies, mass NT-IGFBP4 standard, immunoassay standard and calibrator

  • Analysis:

    Purity ≥90% (Tricine- SDS-PAGE)

    Apparent molecular weight by SDS-PAGE is about 17 000 Da

    Concentration is determined by Lowry method using BSA as a standard

    Antibody pair IBP3 – IBP180 (Cat.# 4IGF4) is specific for Cat.# 8NGP4.

  • Purification:

    Immunoaffinity purification

  • Presentation:

    Lyophilized from 20 mM Tris-HCl, 150 mM NaCl, pH 7.4

    It is recommended to reconstitute this product with deionized water to its initial concentration.

  • Storage:

    Lyophilized -20°C (-15…-30 °C allowed)
    Reconstituted -70 °C (-65 … -80 °C allowed)

  • Other information:

    Avoid repeated freezing and thawing. It is recommended to aliquot the product after reconstitution.

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

  • References:

    See all IGFBP-4 references.
    Search other references from PubMed.

×

Bulk Price Quotation

Recombinant human Insulin-like growth factor binding protein 4, N-terminal fragment (NT-IGFBP-4) (MAb: )

Information

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!